In many cases, research results on miRNAs targeting IL-6 mRNA were in line with our findings in terms of, e.g., HG, inflammation, T2DM, and obesity, while studies that were not in line with our results focused on HFD or HepG2 cells. This evidence concerns the gene IL6 and type 2 diabetes mellitus.